Disruption of MAP7D1 Gene Function Increases the Risk of Doxorubicin-Induced Cardiomyopathy and Heart Failure

Doxorubicin is a cornerstone chemotherapeutic drug widely used to treat various cancers; its dose-dependent cardiomyopathy, however, is one of the leading causes of treatment-associated mortality in cancer survivors. Patients' threshold doses leading to doxorubicin-induced cardiomyopathy (DIC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Li-Ping, Zhong, Jing, Li, Mei-Hang, Sun, Yuan-Chao, Niu, Yu-Juan, Wu, Chuan-Hong, Zhou, Jian-Feng, Norton, Nadine, Li, Zhi-Qiang, Shi, Yong-Yong, Xu, Xiao-Lei, Ding, Yong-He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302367/
https://www.ncbi.nlm.nih.gov/pubmed/34327238
http://dx.doi.org/10.1155/2021/8569921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302367/
https://www.ncbi.nlm.nih.gov/pubmed/34327238
http://dx.doi.org/10.1155/2021/8569921

Ejemplares similares